Log in

Protalix Biotherapeutics SEC Filings & 10K Form (NYSEAMERICAN:PLX)

$0.20
-0.01 (-4.88 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$0.19
Now: $0.20
$0.20
50-Day Range N/A
52-Week Range
$0.17
Now: $0.20
$0.60
Volume107,839 shs
Average Volume549,766 shs
Market Capitalization$28.93 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

Protalix Biotherapeutics (NYSEAMERICAN:PLX) SEC Filings

DateFilerForm TypeView
11/15/2019
4:01 PM
Protalix Biotherapeutics (Filer)
Form DEFA14A
11/12/2019
3:30 PM
Protalix Biotherapeutics (Filer)
Form DEFA14A
11/07/2019
5:59 AM
Protalix Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
5:56 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
7:43 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:30 PM
Protalix Biotherapeutics (Filer)
Form DEF 14A
10/04/2019
3:46 PM
Protalix Biotherapeutics (Filer)
Form PRE 14A
09/24/2019
4:01 PM
Protalix Biotherapeutics (Issuer)
Rubin Eyal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
4:00 PM
Protalix Biotherapeutics (Issuer)
Rubin Eyal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2019
6:21 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
3:15 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
3:13 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:06 PM
Protalix Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
5:19 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
6:09 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
3:05 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
4:56 PM
Bashan Dror (Reporting)
Protalix Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:55 PM
Bashan Dror (Reporting)
Protalix Biotherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/17/2019
6:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
6:09 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
6:00 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
6:35 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
6:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2019
11:16 PM
Protalix Biotherapeutics (Filer)
Form EFFECT
04/12/2019
4:00 PM
Protalix Biotherapeutics (Filer)
Form DEF 14A
03/29/2019
3:06 PM
Protalix Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/18/2019
8:02 AM
Protalix Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2019
6:20 AM
Protalix Biotherapeutics (Filer)
Form 10-Q/A
03/18/2019
6:14 AM
Protalix Biotherapeutics (Filer)
Form 10-Q/A
03/18/2019
6:07 AM
Protalix Biotherapeutics (Filer)
Form 10-Q/A
03/18/2019
5:59 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
2:41 PM
Protalix Biotherapeutics (Subject)
UBS OCONNOR LLC (Filed by)
Form SC 13G/A
02/12/2019
2:07 PM
Nineteen77 Global Multi-Strategy Alpha Master Ltd (Filed by)
Protalix Biotherapeutics (Subject)
Form SC 13G/A
02/08/2019
2:03 PM
CITIGROUP INC (Filed by)
CITIGROUP INC (Filed by)
Protalix Biotherapeutics (Subject)
Form SC 13G/A
02/05/2019
6:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
3:05 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:30 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
6:00 AM
Protalix Biotherapeutics (Filer)
Form DEFA14A
12/17/2018
6:06 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
3:32 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:31 PM
Protalix Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
6:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
3:31 PM
Protalix Biotherapeutics (Filer)
Form DEF 14A
10/05/2018
4:10 PM
Protalix Biotherapeutics (Filer)
Form PRE 14A
10/05/2018
6:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
10:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
3:31 PM
Maimon Yossi (Reporting)
Protalix Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
3:31 PM
Almon Einat Brill (Reporting)
Protalix Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
3:30 PM
Naos Yaron (Reporting)
Protalix Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
3:30 PM
Manor Moshe (Reporting)
Protalix Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
3:30 PM
Protalix Biotherapeutics (Issuer)
Shaaltiel Yoseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
6:45 AM
Granot David (Reporting)
Protalix Biotherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2018
6:10 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
6:12 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2018
3:05 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2018
3:07 PM
Naos Yaron (Reporting)
Protalix Biotherapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/08/2018
3:07 PM
Protalix Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/31/2018
3:15 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
3:05 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
3:07 PM
Protalix Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
6:08 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2018
3:05 PM
Protalix Biotherapeutics (Filer)
Form DEFA14A
04/16/2018
3:06 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2018
1:52 PM
Protalix Biotherapeutics (Filer)
Form CT ORDER
04/02/2018
6:14 AM
Protalix Biotherapeutics (Filer)
Form DEFA14A
03/23/2018
3:35 PM
Protalix Biotherapeutics (Filer)
Form DEFA14A
03/21/2018
3:31 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2018
3:08 PM
Protalix Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2018
6:46 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2018
3:31 PM
Protalix Biotherapeutics (Filer)
Form PRE 14A
02/13/2018
12:24 PM
Protalix Biotherapeutics (Subject)
UBS OCONNOR LLC (Filed by)
Form SC 13G/A
02/12/2018
10:01 AM
Nineteen77 Global Multi-Strategy Alpha Master Ltd (Filed by)
Protalix Biotherapeutics (Subject)
Form SC 13G/A
02/09/2018
12:17 PM
CITIGROUP INC (Filed by)
CITIGROUP INC (Filed by)
Protalix Biotherapeutics (Subject)
Form SC 13G
01/31/2018
6:43 AM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2018
4:03 PM
Abir Therapeutics Ltd (Filed by)
Protalix Biotherapeutics (Subject)
Form SC 13G/A
01/05/2018
3:06 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2017
3:06 PM
Protalix Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 11/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel